3 Interesting Hospital Plays

A deep-dive on three hospital plays — Rainbow Children's Medicare, HCG, and KIMS — across paediatrics, oncology and pan-India multispecialty.

3 Interesting Hospital Plays — cover image

Rainbow Children's Medicare Ltd

1) About the Company

India's largest standalone pediatric-and-perinatal hospital chain, operating 19 hospitals + 5 clinics across six cities with 1,935 beds using a hub-and-spoke model. Founded in 1999 by Dr. Ramesh Kancharla.

2) Key Financial Metrics (FY25)

  • FY25 revenue climbed 17% to ₹1,520 crore
  • 32% EBITDA margin maintained
  • 12% PAT growth achieved
  • Net-cash positive at ~₹700 crore (debt-free balance sheet)

3) Industry Analysis

India Healthcare Market expected to reach ~$372 Bn by 2025; pediatric care is niche yet fast-growing. India has the world's largest child population (26% under age 14), with the segment growing 14–16% CAGR.

4) Business Segments

Pediatrics: NICU, PICU, multi-specialty, organ transplants — 70% of revenue.

Perinatal & Women's Health: Obstetrics, gynecology, fetal medicine, maternal intensive care (~30% revenue); IVF contributes 2.6% and growing 70% YoY.

5) P&L Analysis

Revenue Growth: +16.9% on healthy volume and 8% ARPP uplift despite 3% ARPOB decline. EBITDA Margin: 26.6% as 280 new beds ramped up. PAT Margin: 16.1%.

HCG (Healthcare Global Enterprises Ltd.)

India's largest oncology-focused hospital chain with a pan-India network operating 25+ cancer care centers (including 4 multi-specialty). Headquartered in Bangalore. Founded by Dr. B.S. Ajai Kumar.

  • Revenue grew 16% YoY in FY25 to ₹2,228 Cr
  • EBITDA grew 17% YoY to ₹396 Cr
  • PAT up 19% YoY to ₹74 Cr

Krishna Institute of Medical Sciences Ltd

Leading healthcare chain operating 12 multi-specialty hospitals across Telangana, Andhra Pradesh, and Maharashtra under the KIMS brand. Now expanding into Kerala and Karnataka.

  • ARPOB growth: 22.7% YoY
  • ARPP growth: 9.2% YoY
  • EV/EBITDA: 37.4

This is not stock advice. Content is for informational and research purposes only — please do your own due diligence.

Recent posts

See all blogs →